Wen Lu, Alyssa Ziman, Matthew T S Yan, Allison Waters, Mrigender Singh Virk, Ann Tran, Hongying Tang, Andrew W Shih, Edel Scally, Jay S Raval, Suchi Pandey, Monica B Pagano, Hua Shan, Carmel Moore, Douglas Morrison, Orla Cormack, Joan Fitzgerald, Jennifer Duncan, Jessica Corean, Gwen Clarke, Mark Yazer
BACKGROUND: The clinical significance of serologic reactivity of unidentified specificity (SRUS) in pregnancy is not clear based on available literature. The aim of this study is to determine if SRUS is associated with hemolytic disease of the fetus and newborn (HDFN). STUDY DESIGN AND METHODS: Retrospective data were collected from eight institutions over an 11-year study period (2010-2020), when available (5/8 sites). The outcome of the pregnancies with SRUS-no, mild, moderate, or severe HDFN-was determined...
February 23, 2023: Transfusion